18 SEPTEMBER 2008 NEW ZEALAND GAZETTE, No. 141 3837

Schedule

Product:
Cancidas

Active Ingredient:
Caspofungin acetate 60.6mg equivalent to 50mg caspofungin anhydrous free base

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturers:
Catalent Pharma Solutions LLC, Albuquerque, New Mexico, United States of America
Merck & Co Inc, West Point, Pennsylvania, United States of America

Product:
Cancidas

Active Ingredient:
Caspofungin acetate 83.9mg equivalent to 70mg caspofungin anhydrous free base

Dosage Form:
Powder for infusion

New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited

Manufacturers:
Catalent Pharma Solutions LLC, Albuquerque, New Mexico, United States of America
Merck & Co Inc, West Point, Pennsylvania, United States of America

Dated this 12th day of September 2008.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6872

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product:
Listerine Smart Rinse for Kids 6+ Anti-cavity Fluoride Rinse (Mint Shield Flavour)

Active Ingredients:
Cetylpyridinium chloride, anhydrous 0.03%w/v
Sodium fluoride 0.0221%w/v equivalent to 100 ppm fluoride

Dosage Form:
Mouthwash

New Zealand Sponsor:
Johnson & Johnson Pacific (New Zealand) Limited

Manufacturer:
McNeil Manufacturing Pty Limited, Caringbah, Australia

Product:
Listerine Smart Rinse for Kids 6+ Anti-cavity Fluoride Rinse (Berry Shield Flavour)

Active Ingredients:
Cetylpyridinium chloride, anhydrous 0.03%w/v
Sodium fluoride 0.0221%w/v equivalent to 100 ppm fluoride

Dosage Form:
Mouthwash

New Zealand Sponsor:
Johnson & Johnson Pacific (New Zealand) Limited

Manufacturer:
McNeil Manufacturing Pty Limited, Caringbah, Australia

Dated this 12th day of September 2008.

ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6873

New Zealand Public Health and Disability Act 2000

Appointments/reappointment to District Health Boards (“DHB”)

Counties Manukau DHB

Pursuant to clause 10(1) of Schedule 3 to the New Zealand Public Health and Disability Act 2000 (“the NZPHD Act”), I appoint

Paul Roger Cressey

as deputy chairperson of the Counties Manukau DHB.

This appointment will take effect on 22 September 2008 and will end on 12 September 2009.

South Canterbury DHB

Pursuant to section 29(1)(b) of the NZPHD Act, and notice given under section 28(2) of the Crown Entities Act 2004 (“the CE Act”), I have appointed

Nicola Ann Hornsey

as a member, under section 28(1)(a) of the CE Act, of the South Canterbury DHB.

This appointment will take effect on 15 September 2008 and will end on 12 September 2009.

Wairarapa DHB

Pursuant to section 29(1)(b) of, and clause 2(1)(b) of Schedule 3 to, the NZPHD Act, and notice given under section 28(2) of the CE Act, I have reappointed

Pamela Adrienne Jefferies

as a member, under section 28(1)(a) of the CE Act, of the Wairarapa DHB.

This appointment will take effect on 15 September 2008 and will end on 12 September 2009.

Dated at Wellington this 15th day of September 2008.

HON DAVID CUNLIFFE, Minister of Health.

go6918